ATB Capital Cuts Aurora Cannabis (TSE:ACB) Price Target to C$8.50

Aurora Cannabis (TSE:ACB) had its price target lowered by ATB Capital from C$11.00 to C$8.50 in a report issued on Tuesday morning,BayStreet.CA reports.

Separately, TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. Three analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of C$5.85.

Aurora Cannabis Trading Down 3.8 %

ACB opened at C$5.88 on Tuesday. The firm’s fifty day simple moving average is C$6.89 and its 200 day simple moving average is C$7.56. The stock has a market capitalization of C$321.40 million, a P/E ratio of -9.33 and a beta of 2.71. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. Aurora Cannabis has a 12 month low of C$3.84 and a 12 month high of C$12.85.

Insider Activity at Aurora Cannabis

In other news, Senior Officer Andre Jerome sold 7,712 shares of the business’s stock in a transaction dated Monday, September 23rd. The shares were sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.